STOCK TITAN

INNOVATE Corp. (VATE) grants 12,016 restricted shares to director Avram Glazer

(Neutral)
(Neutral)
Form Type
4

Rhea-AI Filing Summary

GLAZER AVRAM A reported acquisition or exercise transactions in this Form 4 filing.

INNOVATE Corp. director and ten-percent owner Avram A. Glazer received a grant of 12,016 shares of restricted common stock on 2026-08-11 under the company’s Second Amended and Restated 2014 Omnibus Equity Award Plan. These shares vest on the earlier of the first anniversary of the grant or the next regular annual stockholders’ meeting, subject to his continued service. Following this award, he holds 66,000 shares directly, with additional indirect holdings through Lancer Capital LLC and several irrevocable exempt trusts for family members, some of which he may be deemed to beneficially own as trustee.

Positive

  • None.

Negative

  • None.
Insider GLAZER AVRAM A
Role Director, 10% Owner
Type Security Shares Price Value
Grant/Award Common Stock F1 12,016 $0.00 $0.00
holding Common Stock F2 -- -- --
holding Common Stock F3 -- -- --
holding Common Stock F4 -- -- --
holding Common Stock F5 -- -- --
Holdings After Transaction: Common Stock — 66,000 shares (Direct); Common Stock — 2,097,902 shares (Indirect, KAG Irrevocable Exempt Trust); Common Stock — 2,211,805 shares (Indirect, Lancer Capital); Common Stock — 317,244 shares (Indirect, Avram Glazer Irrevocable Exempt Trust); Common Stock — 2,097,902 shares (Indirect, LHG Irrevocable Exempt Trust)
Footnotes (5)
  1. F1. Reflects shares of restricted stock granted pursuant to the INNOVATE Corp. Second Amended and Restated 2014 Omnibus Equity Award Plan, as amended (the "Plan"). The shares will vest and become non-forfeitable on the earlier of (i) the first anniversary of the grant date and (ii) the first regular annual meeting of the Company's stockholders that occurs following the date of grant (subject to continued service with the Company through such vesting date).
  2. F2. The KAG Irrevocable Exempt Trust, is a trust for the benefit of one of Mr. Glazer's children, of which his wife is the trustee.
  3. F3. The reported shares are owned by Lancer Capital LLC ("Lancer"). The Avram Glazer Irrevocable Exempt Trust (the "Trust") is the sole owner of Lancer, and in such capacity may be deemed to beneficially own the shares held of record by Lancer. The Reporting Person is the Trustee of the Trust, and in such capacity may be deemed to beneficially own the shares held of record by Lancer Capital and the Trust.
  4. F4. The reported shares are owned by the Avram Glazer Irrevocable Exempt Trust (the "Trust"). Reporting person is the Trustee of the Trust, and in such capacity may be deemed to beneficially own the shares held of record by the Trust.
  5. F5. The LHG Irrevocable Exempt Trust, is a trust for the benefit of one of Mr. Glazer's children, of which his wife is the trustee.
Restricted stock granted 12,016 shares Restricted common stock granted to Avram A. Glazer on 2026-08-11
Direct holdings after grant 66,000 shares Common stock directly owned by Avram A. Glazer following the award
KAG Irrevocable Exempt Trust holdings 2,097,902 shares Common stock held indirectly via KAG Irrevocable Exempt Trust
Lancer Capital LLC holdings 2,211,805 shares Common stock held by Lancer Capital LLC, owned by an irrevocable exempt trust
Avram Glazer Irrevocable Exempt Trust holdings 317,244 shares Common stock held by the Avram Glazer Irrevocable Exempt Trust
LHG Irrevocable Exempt Trust holdings 2,097,902 shares Common stock held indirectly via LHG Irrevocable Exempt Trust
restricted stock financial
"Reflects shares of restricted stock granted pursuant to the INNOVATE Corp. Second Amended"
Shares granted to an individual that carry limits on transfer or sale until certain conditions are met, such as staying with the company for a set time or hitting performance targets. Think of them as a locked gift that gradually opens; for investors they matter because they affect how many shares may enter the market later, signal management incentives and potential dilution, and reveal confidence in future company performance.
Omnibus Equity Award Plan financial
"granted pursuant to the INNOVATE Corp. Second Amended and Restated 2014 Omnibus Equity Award Plan"
beneficially own financial
"may be deemed to beneficially own the shares held of record by Lancer Capital and the Trust"
Beneficially own means having the economic rights and risks of a security—such as the right to receive dividends, sell the shares, or profit from price changes—whether or not your name appears on the official share register. Think of it like renting a car: you use it and reap the benefits even if the title lists someone else. Investors care because beneficial ownership determines who truly controls value, must be disclosed under securities rules, and can signal potential influence or trading activity that affects a stock’s price.
irrevocable exempt trust financial
"The KAG Irrevocable Exempt Trust, is a trust for the benefit of one of Mr. Glazer's children"

FAQ

What did Avram A. Glazer acquire in this Form 4 for INNOVATE Corp. (VATE)?

Avram A. Glazer was granted 12,016 shares of restricted common stock of INNOVATE Corp. on 2026-08-11. The grant was made under the company’s Second Amended and Restated 2014 Omnibus Equity Award Plan as part of his director compensation.

When do the 12,016 restricted INNOVATE (VATE) shares granted to Avram Glazer vest?

The 12,016 restricted shares will vest on the earlier of one year after the grant date or the first regular annual meeting of stockholders after the grant, provided Avram Glazer continues to serve the company through that vesting date.

How many INNOVATE Corp. (VATE) shares does Avram Glazer hold directly after this grant?

After the restricted stock grant, Avram Glazer holds 66,000 shares of INNOVATE common stock directly. This direct holding is separate from his various indirect holdings through trusts and Lancer Capital LLC reported in the same filing.

Under which plan were Avram Glazer’s restricted INNOVATE (VATE) shares granted?

The 12,016 restricted shares were granted under INNOVATE Corp.’s Second Amended and Restated 2014 Omnibus Equity Award Plan, an equity compensation plan used to issue stock-based awards such as restricted stock.

Does Avram Glazer have trustee or beneficial roles in entities holding INNOVATE (VATE) stock?

Yes. He is trustee of the Avram Glazer Irrevocable Exempt Trust, which owns shares directly and owns Lancer Capital LLC, and in that capacity he may be deemed to beneficially own shares held by Lancer and that trust.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
GLAZER AVRAM A

(Last)(First)(Middle)
C/O WOODS OVIATT GILMAN LLP
1900 BAUSCH & LOMB PLACE

(Street)
ROCHESTER NEW YORK 14604

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
INNOVATE Corp. [ VATE ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirectorX10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
08/11/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock08/11/2026A(1)12,016A$066,000D
Common Stock2,097,902IKAG Irrevocable Exempt Trust(2)
Common Stock2,211,805ILancer Capital(3)
Common Stock317,244IAvram Glazer Irrevocable Exempt Trust(4)
Common Stock2,097,902ILHG Irrevocable Exempt Trust(5)
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
1. Reflects shares of restricted stock granted pursuant to the INNOVATE Corp. Second Amended and Restated 2014 Omnibus Equity Award Plan, as amended (the "Plan"). The shares will vest and become non-forfeitable on the earlier of (i) the first anniversary of the grant date and (ii) the first regular annual meeting of the Company's stockholders that occurs following the date of grant (subject to continued service with the Company through such vesting date).
2. The KAG Irrevocable Exempt Trust, is a trust for the benefit of one of Mr. Glazer's children, of which his wife is the trustee.
3. The reported shares are owned by Lancer Capital LLC ("Lancer"). The Avram Glazer Irrevocable Exempt Trust (the "Trust") is the sole owner of Lancer, and in such capacity may be deemed to beneficially own the shares held of record by Lancer. The Reporting Person is the Trustee of the Trust, and in such capacity may be deemed to beneficially own the shares held of record by Lancer Capital and the Trust.
4. The reported shares are owned by the Avram Glazer Irrevocable Exempt Trust (the "Trust"). Reporting person is the Trustee of the Trust, and in such capacity may be deemed to beneficially own the shares held of record by the Trust.
5. The LHG Irrevocable Exempt Trust, is a trust for the benefit of one of Mr. Glazer's children, of which his wife is the trustee.
Remarks:
/s/ Avram A. Glazer08/13/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)